Dr Mouhamad Khoder

Teaching

I teach a variety of subjects across different courses for UG and PG levels. This includes drug pre-formulation, formulations, smart delivery systems, pharmacokinetics, and pharmaceutical calculations. The modules I contribute to are PY4080, PY5141, PY5100, PY5011, PY6151, PY6021, PY7031, PY7010, CH5005, CH6009, CH6004. I integrate science in practice and use of technology to enhance students experience and outcomes. I use research-informed- and real-world scenario-based teaching to equip students with relevant knowledge and skills for future careers success. I also supervise yearly many BSc (CH6004), MPharm (PY7031) and MSc (CH7100) research projects. I foster collaborative partnership with my students to empower them taking ownership of their research.

Module leadership

I lead several modules at the department of Pharmacy including PY5141 and PY6180. I also led  PY5100, PY5101, PY4130 from 2018-19 to 2024. I focus on integrating science into practice to equip students with knowledge and skills indispensable for future careers success. Students feedback and voice are central in my approach to improves the modules under my leadership.

Curriculum Development 

I contributed to the re-accreditation, design, and validation of different courses at the department of Pharmacy at Kingston University. I led the design of Pharmaceutics division modules according to the new standards and requitements of the General Pharmaceutical Council which led to creating and/or updating several modules. I designed ‘Approaches to Pharmaceutical Manufacturing’ for 2nd year Pre-Pharmacy course and co-designed other modules like ‘Advanced pharmaceutics’ for pharmacy Top-Up year course.

Student Experience & Support

I designed and implemented a peer-led support programme for Pre-Pharmacy course students which expanded to cover several topics. The outcome of this work was published as short case study in AdvancedHE.

Qualifications

• Fellow of Higher Education Academy (SFHEA), 2024
• Fellow of Higher Education Academy (FHEA), 2019.

Courses taught

• Pharmacy MPharm (Hons)
• Pharmaceutical Science MSc
• Pharmaceutical Science BSc (Hons)

I am devoted to research excellence and committed to developing applicable solutions to health and environmental challenges. My multidisciplinary and collaborative research projects, spanning various pharmaceutical and environmental fields, have resulted in several research outputs listed below: 

Research Grants

• 2025 – UKRI Proof-of-concept (£250,000 – Unawarded): Project Leader
• 2024 – ISPF by British Council (£100,000 – Awarded): Project Leader
• 2024 – Academic Research Grant by Qatar Research Development and Innovation Council. (£700,000 – Unawarded): Principal Investigator
• 2022 – Consultancy Contract with SICO-CHEM LTD – Project Leader
• 2015 – Council for At-Risk Academics Fellowship – Personal Award

Doctoral Supervision

Director of study

• Eduardo Ruvolo: – Visible Light and Skin Health: Mechanism of Damage and Photoprotection. PhD by Prior Publications. October 2024. Completed (2025)
• Akash Heer – Developing Scaling-up Technologies to produce Alginate-based Particles for the Removal of Residual Antibiotics. March 2022 – (ongoing).
• Nicole Azizeh – Inactivation of Residual Antibiotics: A Promising Approach to Fight Antimicrobial Resistance. Completed (2025)
• Maria Abedin Zadeh – Fabrication and Evaluation of Maillard Reaction Crosslinked Alginate-Albumin Scaffolds Loaded with Fenofibrate for Retinal Applications. Completed (2023). 

Second Supervisor

• Marwa Megahed – Harnessing Breast Cancer Therapy: Innovative Formulation Strategies for Repurposing Medicines to Overcome Resistance. March 2024 – (ongoing).
• Barzan Osi – Elucidating the Ocular Absorption Pathway of Fasudil Hydrochloride Towards Developing Advanced Ophthalmic Formulations. Completed (2024). 

Third Supervisor

• Ferah Arshad – Formulation and Characterisation of Polycaprolactone Ocular Inserts Loaded with Dexamethasone for Potential Treatment of Uveitis. November 2018 – (ongoing).
• Hannah Denison – Synthesis and investigation of chalcones and curcumin derivatives prior to investigating antimicrobial activity. Completed (2022).
• Nihad Alhashimi – Engineering of Multiparticulate Systems to Modify Drug release Across Orally Disintegrating Tablets. Completed (2021).
• Tanjia Syeda – Discovery and Development of Small Molecule Modulators of the Hippo Signalling Pathway for Enhanced Cancer Immunotherapy. March 2025 – (ongoing).
• Mesk Alshatfa – Hybrid Nanocarriers for Dual Action of Wound Healing and Analgesia in Post-Surgical Wound Care. June 2025 – (ongoing)

Chapters in Edited Books

• M Nakipoğlu, M Khoder, Porous Materials for Tissue Engineering – Chapter 48 in Handbook of Porous Materials, Volume 2, Characterization Techniques and Applications of Porous Materials. Springer Nature (Under review/In-press)

Refereed articles in academic journals

• A Suliman, S Rehmani, B Small, K Butcher, M Khoder, V Kannappan, W Wang, A Elhissi, M Najlah. PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic combination Against Chemoresistant Breast Cancer. Pharmaceuticals (Q1) 18 (4), 487 – 2025.
• N Al-Hashimi, E Dahmash, M Khoder, R Alany, A Elshaer. Engineering pH-Dependent Orally Disintegrating Tablets for Modified Indomethacin Release: A Polymer-Based Approach, AAPS PharmSciTech (Q2). 26 (4), 93.
• N Al-hashimi, E Dahmash, M Khoder, RG Alany, A Elshaer. Systematic screening of particle engineered polymers for the preparation of multiparticulates embedded orally disintegrating tablets. Journal of Drug Delivery Science and Technology (Q1). 101, 106302 – 2024.
• Dumbuya I, Pereira AM, Tolaymat I, Al Dalaty A, Arafat B, Webster M, Pierscionek B, Khoder M, Najlah M. Exploring Disulfiram’s Anticancer Potential: PLGA Nano-Carriers for Prolonged Drug Delivery and Potential Improved Therapeutic Efficacy. Nanomaterials (Q214 (13), 1133) – 2024.
• N Azizeh, A Karam, A Heer, M Najlah, R Singer, RG Alany, SW Gould, M Khoder*. Efficient removal of antibiotics from water by highly crosslinked metal-alginate particles: Preparation, isotherms, kinetics, and microbiological assay. Carbohydrate Polymers (Q1) 326, 121604 – 2024.
• H Kadri, M Alshatfa, FZ Alsalloum, A Elhissi, A Daou. Albumin Nanoparticles in Cancer Therapeutics: Clinical Status, Challenges, and Future Directions. H, M Khoder. Preprint – ChemRxiv – 2024.
• B Osi, AA Al-Kinani, ZK Al-Qaysi, M Khoder, RG Alany. Exploring the Ocular Absorption Pathway of Fasudil Hydrochloride towards Developing a Nanoparticulate Formulation with Improved Performance. Pharmaceutics (Q1) 16 (1), 112 – 2024.
• WW Mustafa, M Khoder, H Abdelkader, R Singer, RG Alany. Interactions of cyclodextrins and their hydroxyl derivatives with etodolac: Solubility and dissolution enhancement. Current Drug Delivery (Q2) 21 (1), 126-139 – 2024.
• M Khoder, H Kadri, R Mukhtar. The impact of Academic Peer Mentoring on Foundation Degree students at Kingston University. Student-led peer learning and support – Short case studies. Page 20. AdvancedHE – 2024.
• A Kaya, B Arafat, H Chichger, I Tolaymat, B Pierscionek, M Khoder, M Najlah. Preparation and Characterisation of Zinc Diethyldithiocarbamate–Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment. Pharmaceutics (Q1) 16 (1), 65 – 2023.
• H Denison, SL Schwikkard, M Khoder, AF Kelly. The chemistry, toxicity and antibacterial activity of curcumin and its analogues. Planta Medica (Q2) 89 (14), P-192 – 2023.
• A Karam & M Khoder. Method for producing of metal-alginate crosslinked particles for the removal of residual antibiotics from biological and environmental media. Patent (EP4190442A1) – 2023.
• M Abedin Zadeh, RG Alany, L Satarian, A Shavandi, M Abdullah Almousa, S Brocchini, M Khoder*. Maillard reaction crosslinked alginate-albumin scaffolds for enhanced fenofibrate delivery to the retina: a promising strategy to treat RPE-related dysfunction. Pharmaceutics (Q1) 15 (5), 1330 – 2023.
• B Osi, M Khoder, AA Al-Kinani, RG Alany. Pharmaceutical, biomedical, and ophthalmic applications of biodegradable polymers (BDPs): Literature and patent review. Pharmaceutical Development and Technology (Q2)27 (3), 341-356 – 2022.
• R Habashy, M Khoder*, A Isreb, MA Alhnan*. A novel multilayer natural coating for fed-state gastric protection. Pharmaceutics (Q1) 14 (2), 283 – 2022.
• WW Mustafa, J Fletcher, M Khoder, RG Alany. Solid dispersions of gefitinib prepared by spray drying with improved mucoadhesive and drug dissolution properties. AAPS PharmSciTech (Q2) 23 (1), 48 – 2022.
• SK Patel, M Khoder, M Peak, MA Alhnan. Controlling drug release with additive manufacturing-based solutions. Advanced drug delivery reviews (Q1) 174, 369-386 – 2021.
• L Dahabra, G Broadberry, A Le Gresley, M Najlah, M Khoder*. Sunscreens containing cyclodextrin inclusion complexes for enhanced efficiency: A strategy for skin cancer prevention. Molecules (Q1) 26 (6), 1698 – 2021.
• A Suliman, M Khoder, I Tolaymat, M Webster, R Alany, W Wang, A Elhissi, M Najlah. Cyclodextrin diethyldithiocarbamate copper ii inclusion complexes: A promising chemotherapeutic delivery system against chemoresistant triple negative breast cancer cell lines. Pharmaceutics (Q1) 13 (1), 84 – 2021.
• R Habashy, M Khoder,S Zhang, B Pereira, M Bohus, J Wang, A Isreb, M A Alhnan. An innovative wax-based enteric coating for pharmaceutical and nutraceutical oral products. M A Alhnan. International Journal of Pharmaceutics (Q1) 591, 119935 – 2020.
• M Khoder. M A Alhnan. A novel natural GRAS-grade enteric coating for pharmaceutical and nutraceutical products. International Journal of Pharmaceutics (Q1) 584, 119392 – 2020.
• MA Zadeh, M Khoder*, AA Al-Kinani, HM Younes, RG Alany. Retinal cell regeneration using tissue engineered polymeric scaffolds. Drug Discovery Today (Q1) 24 (8), 1669-1678 – 2019.
• M Khoder*, HK Gbormoi Sr, A Ryan, A Karam, RG Alany. Potential use of the Maillard reaction for pharmaceutical applications: Gastric and intestinal controlled release alginate-albumin beads. Pharmaceutics (Q1) 11 (2), 83 – 2019.
• M Khoder*, H Abdelkader, A ElShaer, A Karam, M Najlah, RG Alany. The use of albumin solid dispersion to enhance the solubility of unionizable drugs. Pharmaceutical development and technology (Q2) 23 (7), 732-738 – 2018.
• M Najlah, S Freeman, M Khoder, D Attwood, A D’Emanuele. In vitro evaluation of third generation PAMAM dendrimer conjugates. Molecules (Q1) 22 (10), 1661 – 2017.
• M Khoder*, H Abdelkader, A ElShaer, A Karam, M Najlah, RG Alany. Efficient approach to enhance drug solubility by particle engineering of bovine serum albumin. International Journal of Pharmaceutics (Q1) 515 (1-2), 740-748 – 2016.
• A Al Dalaty, A Karam, M Najlah, RG Alany, M Khoder*. Effect of non-cross-linked calcium on characteristics, swelling behaviour, drug release and mucoadhesiveness of calcium alginate beads. Carbohydrate polymers (Q1) 140, 163-170 – 2016.
• M Khoder, N Tsapis, V Domergue-Dupont, C Gueutin, E Fattal. Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads. European Journal of Pharmaceutical Sciences (Q1) 41 (2), 281-288 –  2010.
• M Khoder, N Tsapis, E Fattal. Mechanisms of antibiotic resistance and delivery strategies to prevent its emergence. Journal of drug delivery science and technology(Q1) 20 (6), 407-418 – 2010.
• M Khoder, N Tsapis, H Huguet, M Besnard, C Gueutin, E Fattal. Removal of ciprofloxacin in simulated digestive media by activated charcoal entrapped within zinc-pectinate beads. International journal of pharmaceutics (Q1) 379 (2), 251-259 – 2009.

Conferences Presentations and Seminars

• Nicole Azizeh, M Khoder, Fighting Antimicrobial Resistance via Removal of Antibiotics Residues from Water. World Congress on Infectious Diseases, June 2025 Rome, Italy.
• H Denison, A Kelly, S Schwikkard, M Khoder. Investigation into the Synthesis and Antibacterial Activity of Curcumin Analogues against Gram-positive and Gram-negative Bacteria Planta Medica, Trinity College Dublin Ireland. July 2023
• M Khoder, A Vangala. Impact of Covid-19 pandemic-imposed teaching and assessment practices on student performance. Oral presentation. Higher Education Institutional Research (HEIR) Conference, Kingston University, 2023
• B Osi, M Khoder, A Al-Kinani, R Alany. Optimisation of Fasudil Hydrochloride Particulate Formulation Using Statistical Experimental design. JPAG Pharmaceutical Research Award & Career Symposium. Royal Society of Chemistry, London. 2022
• N Al-Hashimi, R Alany, M Khoder, Amr Elshaer.Oro-dispersible tablets of modified indomethacin release across the particulate system. APS International PharmSci, University of Greenwich. 2019
• N Al-Hashimi, R Alany, M Khoder, Amr Elshaer.Modification of indomethacin release across Oro-dispersible tablets using pH-dependent polymers. Sheffield university (Workshop), Switzerland, 2019.
• N Al-Hashimi, R Alany, M Khoder, Amr Elshaer.Modification of indomethacin release using Oro--dispersible tablets through Eudragit L100 pellets. Royal Society of Chemistry event, Kingston University London, 2019.
• N Al-Hashimi, A Hodon, R Alany, M Khoder, Amr Elshaer. The correlation between particle size and elastic properties of pharmaceutical polymers. University of Strathclyde, 2017.
• Khoder, M., Karam, A., Najlah, M., Alany, R. Effect of non-cross-linked calcium on properties, swelling behaviour, drug release and muco-adhesiveness of calcium alginate beads. UKICRS Symposium, Cardiff, UK. 2016.
• M. Khoder, N Tsapis, E Fattal. poster presentation, Pharmaceutical Sciences Fair & Exhibition, Malta. 2010.
• M. Khoder, N. Tsapis, E Fattal, Delivery Systems for the Removal of Colonic Residual Antibiotic to Reduce the Emergence of Antimicrobial Resistances, 36th Annual Meeting & Exposition of the Controlled Release Society, Copenhagen 2009.
• M. Khoder, N. Tsapis, EF XXIIIth Scientific GTRV meeting, Anger, France, 2008.
• M Khoder, N Tsapis Elias Fattal, XXIIth Scientific GTRV meeting, Strasbourg, France, December 2007.